Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026

Get updates on Theralase Technologies Inc. delivered in your email.

Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Bullboard (TSXV:TLT)

View:

Comment by CancerSlayeron Nov 22, 2024 2:05am

RE:RE:RE:RE:RE:Next NR

..."paradoxically beneficial" would have been a better choice of words. As this tech gains more attention/acceptance as dictated by the science/results, more sound decision-making can ...more

Discussion

Comment by 2b7f6fabon Nov 22, 2024 12:22am

RE:As The Saying Goes …..

Yep yep yep, As the saying goes, stay awesome, stay positive, and carry on. (Nothing is ever accomplished with a negative attitude.)

Discussion

Comment by rhodiumdon Nov 21, 2024 9:01pm

RE:RE:RE:RE:Next NR

I understand what you're trying to say but I wouldn't go as far as calling it "nice". Let's all keep in mind that there are very real people going through hell involved in those ...more

141

Discussion

Comment by Eoganachton Nov 21, 2024 8:21pm

RE:RE:RE:Next NR

I am very much looking forward to news from the CRA (Collaborative Research Agreement) with the National Microbiology Laboratory, Public Health Agency of Canada (“PHAC”) before the end of the ...more

166

Discussion

Post by beenthereon Nov 21, 2024 8:10pm

As The Saying Goes …..

Of all boards that I have followed over the years ( and there have been many ) this one takes the world record for being the most positive! but ...... As the saying goes .... if it sounds too good ...more

142

Discussion

Comment by CancerSlayeron Nov 21, 2024 7:23pm

RE:RE:RE:Next NR

In terms of de-risking, it's nice to also have the competition do some of the dirty work & lend us a hand by either underperforming &/or carrying excessive toxicity, all the while ...more

121

Discussion

Comment by DJDawgon Nov 21, 2024 6:50pm

RE:RE:Next NR

All the good discussion about the bladder study makes me want to iterate that TLT is not a one drug and one indication company. IV Ruvidar (Rutherrin) shows great promise for solid and liquid tumours ...more

128

Discussion

Comment by Eoganachton Nov 21, 2024 5:06pm

RE:Next NR

We should get the 3Q2024 financials and MD&A by the end of next week.

Discussion

Post by rhodiumdon Nov 21, 2024 4:35pm

Next NR

Next NR could very well be BTD approval... Tic toc...

138

Discussion

Comment by CancerSlayeron Nov 21, 2024 3:44pm

RE:RE:FDA focused?

An FDA that lacks a revolving door would be a good start.

Discussion

Comment by CancerSlayeron Nov 21, 2024 3:40pm

RE:New BCG-Unresponsive NMIBC Treatment Review Study

Thanks Eoganacht....All factors considered (our current 12 month CR at ~27% & 12 month ORR at 71% across 68 patients, excellent safety profile & likely high cost-effectiveness...considering we ...more

167

Discussion

Comment by bmk211on Nov 21, 2024 3:12pm

RE:FDA focused?

I was worried about the same thing. But truthfully as hard as it may seem to belive. Things usually do get worse before they get better when corruption is involved. But in the ...more

134

Discussion

Post by Gman620on Nov 21, 2024 1:53pm

FDA focused?

I hope that the people at the FDA are not distracted by shredding documents and doing CYA activities instead of doing their job and pushing through this BTD. Any indication that things are on hold ...more

199

Discussion

Comment by Galaxym31on Nov 21, 2024 1:21pm

RE:RE:Went back 17 pages on Dumbles post pages

Sensitive boy .

Discussion

Comment by StevenBirchon Nov 21, 2024 12:10pm

RE:New BCG-Unresponsive NMIBC Treatment Review Study

Sounds to me like TLT, facing long odds and great difficulty, is...{^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com/watch?v=qrvP02Oit04|(fs)True|(loop)False|(autoplay ...more

218

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

Connect with V.TLT

INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

The Road to Saving Lives: Clinical Study Underway

Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
Best-in-class treatment for NMIBC (according to interim clinical data)
NMIBC (Non-Muscle-Invasive Bladder Cancer)

FACT SHEET

The Watchlist

< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
Best-in-class treatment for NMIBC (according to interim clinical data)
NMIBC (Non-Muscle-Invasive Bladder Cancer)

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Get updates on Theralase Technologies Inc. delivered in your email.

Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (TSXV:TLT)

Connect with V.TLT

Investor Presentation

FACT SHEET

The Watchlist

Investment Opportunity

Facebook

Contact Us